June 10, 2019 | Vensana Capital® Events

Justin Klein featured at Virginia Bio Insights at University of Virginia Darden School of Business

20

Novel FDA PMA & de novo 510k approvals

55

U.S. Commercial Product Launches

39

Level I Clinical Trials

29

Strategic Financings

30

Exits by IPO or M&A